MAR 20, 2019 11:39 AM PDT

First Drug for Postpartum Depression

WRITTEN BY: Nouran Amin

The U.S. Food and Drug Administration recently approved the first ever drug specifically for the treatment of postpartum depression--a common and often devastating condition for new mothers which interferes with the maternal-infant bond. The approval of the drug came after the success of two clinical trials."Postpartum depression is a serious condition that, when severe, can be life-threatening," noted the FDA's Dr. Tiffany Farchione, who is acting director of the Division of Psychiatry Products in the agency's Center for Drug Evaluation and Research. "Women may experience thoughts about harming themselves or harming their child."

The drug is called Zulesso (brexanolone) and would be delivered intravenously.

"There is tremendous stigma around postpartum depression for women. Many women experience great shame and feel inadequate as mothers if they struggle with depression at a time that is supposed to be joyous ," says Dr. Martha Wald, a psychiatrist and psychoanalyst at Duke University, in Winston-Salem, N.C. "Because of this stigma, many women choose to not seek help and endure great suffering in silence," she said. "Postpartum depression affects 15 to 20 percent of the general population, and at least half of this group goes untreated. As more targeted treatments like this become available, more mothers are likely to seek and benefit from treatment."

Zulesso is different than any other antidepressant as it specifically acts on the main inhibitory neurotransmitter system of the brain, the GABA system. The drug also cocnatins an aturally occurring steroid in the body—allopregnanolone. "Allopregnanolone is known to modulate the stress response system in humans, which has been shown to be abnormally functioning in women with postpartum depression," explained Dr. Kristina Deligiannidis, the lead investigator on the clinical trials that led to Zulesso's approval.

Source: MedicalXpress.com

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
New Painkiller More Effective than Opioids Discovered in Mud
Researchers have discovered a new painkiller dubbed to be as effective as opioids, only minus their disadvantages, from a 16-year old mud sample found near...
DEC 02, 2019
Drug Discovery & Development
DEC 02, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Drug Targets Against The Nipah Virus
The Nipah virus, first identified in 1998 and is transmitted from pigs and bats, has resulted in a high mortality rate killing more than half of all infect...
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries
Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of re...
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Magic Mushrooms Pass First Clinical Trial Against Depression
With the efficacy of selective serotonin reuptake inhibitors such as Prozac increasingly coming under question, the search for new pharmaceutical treatment...
JAN 21, 2020
Cannabis Sciences
JAN 21, 2020
Medical Marijuana Ineffective for Long Term Pain Management
Medicinal cannabis may not as effective as once thought as a solution for sleep problems for those with chronic pain in the long run, according to new find...
Loading Comments...